Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Feb 12 2019

Full Issue

In Era Of Public Rage Over Drug Prices, Cory Booker Is Haunted By His Past Relationship With 'Big Pharma'

As Sen. Cory Booker (D-N.J.) eyes the 2020 White House race, he's scrambling to mitigate any damage that may have been done by his decision to accept campaign donations from pharmaceutical companies. As public outrage boils over about high drug prices, most presidential contenders, such as Sen. Amy Klobuchar (D-Minn.), are trying to get in front of the issue by offering plans they believe will demonstrate a hard stance against Big Pharma.

Stat: Cory Booker Looks To Shake His Reputation For Drug Industry Coziness

For the past two years, [Cory] Booker has been repeatedly reminded of that kind of anger over high drug prices — and hounded by criticism that he has an overly cozy relationship with the pharma industry. Last week, the hosts of “Pod Save America,” a progressive political podcast, said he had taken “a bad vote on pharmaceuticals.” A viral Facebook video viewed nearly a quarter-million times questions whether Booker is a “Big Pharma” candidate. And on the left-leaning “Breakfast Club” radio show last week, Booker was pointedly asked whether he could be trusted to hold large pharmaceutical companies accountable. That reputation, deserved or not, could become a major political liability for Booker, particularly at a time of concern over drug prices and in a race with other progressive lawmakers like Sens. Elizabeth Warren and Bernie Sanders whose disdain for large drug companies is palpable. (Facher, 2/12)

The Washington Post: Sen. Amy Klobuchar’s 2020 Policy Agenda: Lower Drug Costs, Prepare For ‘Digital Disruption,’ Expand Savings Accounts

Sen. Amy Klobuchar (D-Minn.) is running for president on a policy agenda of lowering prescription drug costs, expanded savings accounts to help people save for their educations, and a slew of Internet-related policies, including expanding rural broadband and tougher privacy laws, according to aides to the senator. Klobuchar, who has withheld her support from the more liberal proposals made by Democratic lawmakers, will also push for automatically registering all eligible voters, an overhaul of election security, and committing the United States to the Paris agreement to combat climate change, aides said. (Stein, 2/11)

Meanwhile —

The Wall Street Journal: Medicare For All Bill Puts Pressure On Democrats’ 2020 Field

House Democrats are planning to unveil Medicare for All legislation soon, turning up the heat on Democratic presidential candidates facing questions over how far they want to go in embracing a national government health system. The bill from Rep. Pramila Jayapal and other House Democrats is expected to closely mirror a Senate Medicare for All bill from Sen. Bernie Sanders (I., Vt.), which would expand government-run health insurance to all and do away with the current system of employer-provided coverage. At the same time, more than 100 organizing events will take place this week nationwide to help build grass-roots support for Medicare for All. (Armour, 2/11)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF